Terms: = Leukemia AND MUC16, CA125, CA-125
37 results:
1. Engineered exosome as a biological nanoplatform for drug delivery of Rosmarinic acid to improve implantation in mice with induced endometritis.
Taravat M; Asadpour R; Jafari Jozani R; Fattahi A; Khordadmehr M; Hajipour H
Syst Biol Reprod Med; 2024 Dec; 70(1):3-19. PubMed ID: 38323586
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Factors and Long-term Treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood leukemia Survivors: An Exome-Wide Association Study.
Petrykey K; Lippé S; Sultan S; Robaey P; Drouin S; Affret-Bertout L; Beaulieu P; St-Onge P; Baedke JL; Yasui Y; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):234-243. PubMed ID: 38051303
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia.
Huang W; Zheng S; Wang Q; Zhao N; Long Z
Sci Rep; 2023 Sep; 13(1):15658. PubMed ID: 37730831
[TBL] [Abstract] [Full Text] [Related]
4. A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer.
Dobilas A; Åkesson A; Leandersson P; Borgfeldt C
Cancer Genomics Proteomics; 2023; 20(3):273-280. PubMed ID: 37093685
[TBL] [Abstract] [Full Text] [Related]
5. Gene mutation analysis using next-generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi-center study from China.
Li J; Pei L; Liang S; Xu S; Wang Y; Wang X; Liao Y; Zhan Q; Cheng W; Yang Z; Tang X; Zhang H; Xiao Q; Chen J; Liu L; Wang L
Cancer Med; 2023 Apr; 12(8):9332-9350. PubMed ID: 36799265
[TBL] [Abstract] [Full Text] [Related]
6. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.
Hua J; Ding T; Shao Y
Front Immunol; 2022; 13():1040661. PubMed ID: 36591215
[TBL] [Abstract] [Full Text] [Related]
7. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia.
Canh NX; Giang NV; Nghia VX; Sopjani M; Ngan NTT; Hoang NH; Xuan NT
J Recept Signal Transduct Res; 2021 Aug; 41(4):331-338. PubMed ID: 32808859
[TBL] [Abstract] [Full Text] [Related]
9. Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.
Ma J; Ren S; Ding J; Liu S; Zhu J; Ma R; Meng F
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285390
[TBL] [Abstract] [Full Text] [Related]
10. Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System.
Avanzi MP; Yeku O; Li X; Wijewarnasuriya DP; van Leeuwen DG; Cheung K; Park H; Purdon TJ; Daniyan AF; Spitzer MH; Brentjens RJ
Cell Rep; 2018 May; 23(7):2130-2141. PubMed ID: 29768210
[TBL] [Abstract] [Full Text] [Related]
11. Controversies in the management of ovarian tumours in prepubertal children - A BAPS and UK CCLG Surgeons Cancer Group National Survey.
Braungart S; Craigie RJ; Losty PD
J Pediatr Surg; 2018 Nov; 53(11):2231-2234. PubMed ID: 29395152
[TBL] [Abstract] [Full Text] [Related]
12. Could mucin 16 and colony-stimulating factor 2-receptor beta possible graft versus host disease biomarkers? Medical hypotheses.
Souza MM; de Paula FM; Hsieh R; Macedo MC; Corral MA; Nunes TB; De Paula F; Lourenço SV
Med Hypotheses; 2017 Mar; 100():89-93. PubMed ID: 28236856
[TBL] [Abstract] [Full Text] [Related]
13. HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer.
Wang Y; Li M; Meng F; Lou G
Hum Pathol; 2017 Feb; 60():114-120. PubMed ID: 27818289
[TBL] [Abstract] [Full Text] [Related]
14. The effects of PTBP3 silencing on the proliferation and differentiation of MKN45 human gastric cancer cells.
Chen B; Zhao AG; Shao J; Mu XY; Jiang L; Liu JW
Life Sci; 2014 Sep; 114(1):29-35. PubMed ID: 25119103
[TBL] [Abstract] [Full Text] [Related]
15. CEA, AFP, ca125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract] [Full Text] [Related]
16. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
[TBL] [Abstract] [Full Text] [Related]
17. Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
Shoji T; Takatori E; Omi H; Kumagai S; Yoshizaki A; Yokoyama Y; Mizunuma H; Fujimoto T; Takano T; Yaegashi N; Tase T; Nakahara K; Kurachi H; Nishiyama H; Sugiyama T
Int J Gynecol Cancer; 2011 Jan; 21(1):44-50. PubMed ID: 21330830
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical and biological features of 8 patients with Richter's syndrome].
Zhu HY; Xu W; Miao KR; Hong M; Fang C; Zhu DX; Wu YJ; Qiao C; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1499-504. PubMed ID: 21176359
[TBL] [Abstract] [Full Text] [Related]
19. [Identification and characterization of ovarian cancer stem-like cells from primary tumor.].
Lai DM; Liu T; Huang Y; Wang LH; Zhang J; Cheng WW
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):936-40. PubMed ID: 20193423
[TBL] [Abstract] [Full Text] [Related]
20. muc16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.
Gubbels JA; Felder M; Horibata S; Belisle JA; Kapur A; Holden H; Petrie S; Migneault M; Rancourt C; Connor JP; Patankar MS
Mol Cancer; 2010 Jan; 9():11. PubMed ID: 20089172
[TBL] [Abstract] [Full Text] [Related]
[Next]
